Beijing Kawin Technology Share-holding Co Ltd Market Cap ($388.48 Million)
Market Cap & Net Worth: Beijing Kawin Technology Share-holding Co Ltd (688687)
Beijing Kawin Technology Share-holding Co Ltd market cap. Beijing Kawin Technology Share-holding Co Ltd (SHG:688687) has a market capitalization of $388.48 Million (CN¥2.65 Billion) as of November 1, 2026. Listed on the SHG stock exchange, this China-based company holds position #13219 globally and #3846 in its home market, demonstrating a -3.24% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Beijing Kawin Technology Share-holding Co Ltd's stock price CN¥15.53 by its total outstanding shares 170944422 (170.94 Million). Also see 688687 cash flow metrics for how efficiently the company converts equity into cash flow.
Beijing Kawin Technology Share-holding Co Ltd Market Cap History (2021–2026)
Beijing Kawin Technology Share-holding Co Ltd market cap history from 2021 to 2026. Data shows change from $663.80 Million to $388.48 Million (-15.44% CAGR). Check Beijing Kawin Technology Share-holding C share price for real-time trading data and today's change.
Beijing Kawin Technology Share-holding Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Beijing Kawin Technology Share-holding Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Beijing Kawin Technology Share-holding C (688687) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.47x
Beijing Kawin Technology Share-holding Co Ltd's market cap is 0.47 times its annual revenue
Latest Price to Earnings (P/E) Ratio
21.04x
Beijing Kawin Technology Share-holding Co Ltd's market cap is 21.04 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $663.80 Million | $1.14 Billion | $107.29 Million | 0.58x | 6.19x |
| 2022 | $560.30 Million | $1.16 Billion | $83.41 Million | 0.48x | 6.72x |
| 2023 | $864.72 Million | $1.41 Billion | $116.52 Million | 0.61x | 7.42x |
| 2024 | $539.81 Million | $1.23 Billion | $142.37 Million | 0.44x | 3.79x |
| 2025 | $623.36 Million | $1.32 Billion | $29.63 Million | 0.47x | 21.04x |
Competitor Companies of 688687 by Market Capitalization
Companies near Beijing Kawin Technology Share-holding Co Ltd in the global market cap rankings as of November 1, 2026. Also see 688687 current and non-current assets for a full breakdown of the balance sheet.
Key companies related to Beijing Kawin Technology Share-holding Co Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #182 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #371 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $68.91 Billion USD ( AU$97.38 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #495 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #182 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $558.88 |
| #371 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $927.89 |
| #412 | CSL Ltd | AU:CSL | $68.91 Billion | AU$200.73 |
| #495 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $221.72 |
Market Capitalization of Beijing Kawin Technology Share-holding Co Ltd (2021–2026)
Market capitalization of Beijing Kawin Technology Share-holding Co Ltd from 2021 to today. Between 2021 and today, Beijing Kawin Technology Share-holding Co Ltd's market cap moved from $663.80 Million to $ 388.48 Million, with a yearly change of -15.44%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥388.48 Million | -37.68% |
| 2025 | CN¥623.36 Million | +15.48% |
| 2024 | CN¥539.81 Million | -37.57% |
| 2023 | CN¥864.72 Million | +54.33% |
| 2022 | CN¥560.30 Million | -15.59% |
| 2021 | CN¥663.80 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Beijing Kawin Technology Share-holding Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $388.48 Million USD |
| MoneyControl | $388.48 Million USD |
| MarketWatch | $388.48 Million USD |
| marketcap.company | $388.48 Million USD |
| Reuters | $388.48 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Beijing Kawin Technology Share-holding Co Ltd
Beijing Kawin Technology Share-Holding Co., Ltd., a biopharmaceutical company, provides treatment solutions for viral and immune diseases in China and internationally. The company offers recombinant human interferon alfa-2b injection; interferon alfa-2b vaginal effervescent tablets; coblopasvir hydrocholoride capsules; sofosbuvir tablets; peginterferon alfacon-2 injection; and compound glycyrrhiz… Read more